AIHealthcare Analytics

Knowledge Wiki

Wiki › UK Unveils New Policy to Constantly Monitor AI-Based Medical Devices

UK Unveils New Policy to Constantly Monitor AI-Based Medical Devices

OVERVIEW
Rev 4 Oct 6, 2026 18:59 UTC 1 sources

The United Kingdom has announced new regulatory policy requiring continuous monitoring of AI-based medical devices after market approval. This represents a shift from traditional post-market surveillance (passive reporting of adverse events) to active, real-time monitoring of AI system performance. The UK approach acknowledges that AI systems may degrade over time, may perform differently in different patient populations or clinical contexts, and may require updates or retraining based on real-world performance data. Continuous monitoring enables regulators to identify performance problems quickly and mandate corrective actions. However, continuous monitoring creates operational complexity for health systems: they must implement infrastructure for capturing and reporting AI system performance data, must participate in regulatory data sharing, and must be prepared to modify or discontinue AI systems if monitoring reveals problems. The UK model will likely be adapted by other regulators as AI medical device adoption increases. ---

Sources: harvested
🔒

Subscribe to read full wiki analysis

Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.

View Plans & Subscribe

New users get a 7-day trial — no credit card required.

← Back to Wiki Index